ID   FN3K_HUMAN              Reviewed;         309 AA.
AC   Q9H479;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   18-JUN-2025, entry version 174.
DE   RecName: Full=Fructosamine-3-kinase {ECO:0000303|PubMed:11016445};
DE            EC=2.7.1.171 {ECO:0000269|PubMed:11016445, ECO:0000269|PubMed:11522682};
DE   AltName: Full=Protein-psicosamine 3-kinase FN3K {ECO:0000305};
DE   AltName: Full=Protein-ribulosamine 3-kinase FN3K {ECO:0000305};
DE            EC=2.7.1.172 {ECO:0000269|PubMed:14633848};
GN   Name=FN3K {ECO:0000303|PubMed:14633848, ECO:0000312|HGNC:HGNC:24822};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 1-6; 30-41; 50-63; 76-92;
RP   103-116; 121-130 AND 173-190, ACETYLATION AT MET-1, FUNCTION, CATALYTIC
RP   ACTIVITY, SUBUNIT, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=11016445; DOI=10.2337/diabetes.49.10.1627;
RA   Delpierre G., Rider M.H., Collard F., Stroobant V., Vanstapel F.,
RA   Santos H., Van Schaftingen E.;
RT   "Identification, cloning, and heterologous expression of a mammalian
RT   fructosamine-3-kinase.";
RL   Diabetes 49:1627-1634(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 16-26; 30-41; 76-92; 103-116; 119-130; 132-142;
RP   173-187; 258-265; 270-276 AND 298-305, FUNCTION, CATALYTIC ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11522682; DOI=10.2337/diabetes.50.9.2139;
RA   Szwergold B.S., Howell S., Beisswenger P.J.;
RT   "Human fructosamine-3-kinase: purification, sequencing, substrate
RT   specificity, and evidence of activity in vivo.";
RL   Diabetes 50:2139-2147(2001).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   FUNCTION.
RX   PubMed=11975663; DOI=10.1042/bj20020325;
RA   Delpierre G., Collard F., Fortpied J., Van Schaftingen E.;
RT   "Fructosamine 3-kinase is involved in an intracellular deglycation pathway
RT   in human erythrocytes.";
RL   Biochem. J. 365:801-808(2002).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=14633848; DOI=10.2337/diabetes.52.12.2888;
RA   Collard F., Delpierre G., Stroobant V., Matthijs G., Van Schaftingen E.;
RT   "A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-
RT   kinase acting on psicosamines and ribulosamines but not on fructosamines.";
RL   Diabetes 52:2888-2895(2003).
CC   -!- FUNCTION: Fructosamine-3-kinase involved in protein deglycation by
CC       mediating phosphorylation of fructoselysine residues on glycated
CC       proteins, to generate fructoselysine-3 phosphate (PubMed:11016445,
CC       PubMed:11522682, PubMed:11975663). Fructoselysine-3 phosphate adducts
CC       are unstable and decompose under physiological conditions
CC       (PubMed:11522682, PubMed:11975663). Involved in intracellular
CC       deglycation in erythrocytes (PubMed:11975663). Involved in the response
CC       to oxidative stress by mediating deglycation of NFE2L2/NRF2, glycation
CC       impairing NFE2L2/NRF2 function (By similarity). Also able to
CC       phosphorylate psicosamines and ribulosamines (PubMed:14633848).
CC       {ECO:0000250|UniProtKB:Q9ER35, ECO:0000269|PubMed:11016445,
CC       ECO:0000269|PubMed:11522682, ECO:0000269|PubMed:11975663,
CC       ECO:0000269|PubMed:14633848}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-(D-fructosyl)-L-lysyl-[protein] + ATP = N(6)-(3-O-
CC         phospho-D-fructosyl)-L-lysyl-[protein] + ADP + H(+);
CC         Xref=Rhea:RHEA:59832, Rhea:RHEA-COMP:15451, Rhea:RHEA-COMP:15452,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:143253,
CC         ChEBI:CHEBI:143254, ChEBI:CHEBI:456216; EC=2.7.1.171;
CC         Evidence={ECO:0000269|PubMed:11016445, ECO:0000269|PubMed:11522682};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59833;
CC         Evidence={ECO:0000269|PubMed:11016445, ECO:0000269|PubMed:11522682};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-D-ribulosyl-L-lysyl-[protein] + ATP = N(6)-(3-O-phospho-
CC         D-ribulosyl)-L-lysyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:48432,
CC         Rhea:RHEA-COMP:12103, Rhea:RHEA-COMP:12104, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:90418, ChEBI:CHEBI:90420,
CC         ChEBI:CHEBI:456216; EC=2.7.1.172;
CC         Evidence={ECO:0000269|PubMed:14633848};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48433;
CC         Evidence={ECO:0000269|PubMed:14633848};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-(D-psicosyl)-L-lysyl-[protein] + ATP = N(6)-(3-O-phospho-
CC         D-psicosyl)-L-lysyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:61392,
CC         Rhea:RHEA-COMP:15796, Rhea:RHEA-COMP:15797, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:144621, ChEBI:CHEBI:144622,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:14633848};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61393;
CC         Evidence={ECO:0000269|PubMed:14633848};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10 uM for deoxymorpholinofructose {ECO:0000269|PubMed:14633848};
CC         KM=160 uM for deoxymorpholinopsicose {ECO:0000269|PubMed:14633848};
CC         KM=140 uM for Psicoselysine {ECO:0000269|PubMed:14633848};
CC         KM=2.6 uM for deoxymorpholinoribulose {ECO:0000269|PubMed:14633848};
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11016445}.
CC   -!- TISSUE SPECIFICITY: Widely expressed (PubMed:11522682). Expressed in
CC       erythrocytes (PubMed:11016445). {ECO:0000269|PubMed:11016445,
CC       ECO:0000269|PubMed:11522682}.
CC   -!- SIMILARITY: Belongs to the fructosamine kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ404615; CAC16393.1; -; mRNA.
DR   EMBL; BC042680; AAH42680.1; -; mRNA.
DR   CCDS; CCDS11818.1; -.
DR   RefSeq; NP_071441.1; NM_022158.4.
DR   PDB; 8UE1; X-ray; 2.85 A; A=1-309.
DR   PDB; 9CX8; X-ray; 1.67 A; A/B=1-116, A/B=139-309.
DR   PDB; 9CXM; X-ray; 1.76 A; A/B=1-116, A/B=139-309.
DR   PDB; 9CXN; X-ray; 1.90 A; A/B=1-116, A/B=139-309.
DR   PDB; 9CXO; X-ray; 2.32 A; A/B=1-116, A/B=139-309.
DR   PDB; 9CXV; X-ray; 1.80 A; A/B=1-116, A/B=139-309.
DR   PDB; 9CXW; X-ray; 1.80 A; A/B=1-116, A/B=139-309.
DR   PDBsum; 8UE1; -.
DR   PDBsum; 9CX8; -.
DR   PDBsum; 9CXM; -.
DR   PDBsum; 9CXN; -.
DR   PDBsum; 9CXO; -.
DR   PDBsum; 9CXV; -.
DR   PDBsum; 9CXW; -.
DR   AlphaFoldDB; Q9H479; -.
DR   SMR; Q9H479; -.
DR   BioGRID; 122075; 17.
DR   FunCoup; Q9H479; 64.
DR   IntAct; Q9H479; 10.
DR   STRING; 9606.ENSP00000300784; -.
DR   GlyGen; Q9H479; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H479; -.
DR   PhosphoSitePlus; Q9H479; -.
DR   SwissPalm; Q9H479; -.
DR   BioMuta; FN3K; -.
DR   DMDM; 13959371; -.
DR   jPOST; Q9H479; -.
DR   MassIVE; Q9H479; -.
DR   PaxDb; 9606-ENSP00000300784; -.
DR   PeptideAtlas; Q9H479; -.
DR   ProteomicsDB; 80792; -.
DR   Pumba; Q9H479; -.
DR   Antibodypedia; 33043; 175 antibodies from 26 providers.
DR   DNASU; 64122; -.
DR   Ensembl; ENST00000300784.8; ENSP00000300784.7; ENSG00000167363.14.
DR   GeneID; 64122; -.
DR   KEGG; hsa:64122; -.
DR   MANE-Select; ENST00000300784.8; ENSP00000300784.7; NM_022158.4; NP_071441.1.
DR   UCSC; uc010wvs.2; human.
DR   AGR; HGNC:24822; -.
DR   CTD; 64122; -.
DR   DisGeNET; 64122; -.
DR   GeneCards; FN3K; -.
DR   HGNC; HGNC:24822; FN3K.
DR   HPA; ENSG00000167363; Low tissue specificity.
DR   MIM; 608425; gene.
DR   OpenTargets; ENSG00000167363; -.
DR   VEuPathDB; HostDB:ENSG00000167363; -.
DR   eggNOG; KOG3021; Eukaryota.
DR   GeneTree; ENSGT00390000005730; -.
DR   HOGENOM; CLU_036517_0_1_1; -.
DR   InParanoid; Q9H479; -.
DR   OMA; CNRFGDE; -.
DR   OrthoDB; 5772781at2759; -.
DR   PAN-GO; Q9H479; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9H479; -.
DR   BioCyc; MetaCyc:ENSG00000167363-MONOMER; -.
DR   BRENDA; 2.7.1.171; 2681.
DR   PathwayCommons; Q9H479; -.
DR   Reactome; R-HSA-163841; Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation.
DR   SignaLink; Q9H479; -.
DR   BioGRID-ORCS; 64122; 13 hits in 1158 CRISPR screens.
DR   CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities.
DR   ChiTaRS; FN3K; human.
DR   GeneWiki; FN3K; -.
DR   GeneWiki; Fructosamine-3-kinase; -.
DR   GenomeRNAi; 64122; -.
DR   Pharos; Q9H479; Tbio.
DR   PRO; PR:Q9H479; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9H479; protein.
DR   Bgee; ENSG00000167363; Expressed in sural nerve and 92 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IBA:GO_Central.
DR   GO; GO:0102194; F:protein-fructosamine 3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0102193; F:protein-ribulosamine 3-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0030389; P:fructosamine metabolic process; IBA:GO_Central.
DR   GO; GO:0030393; P:fructoselysine metabolic process; NAS:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0036525; P:protein deglycation; IDA:UniProtKB.
DR   FunFam; 3.90.1200.10:FF:000003; fructosamine-3-kinase isoform X1; 1.
DR   FunFam; 3.30.200.20:FF:000264; Protein-ribulosamine 3-kinase, chloroplastic; 1.
DR   Gene3D; 3.90.1200.10; -; 1.
DR   Gene3D; 3.30.200.20; Phosphorylase Kinase, domain 1; 1.
DR   InterPro; IPR016477; Fructo-/Ketosamine-3-kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   PANTHER; PTHR12149; FRUCTOSAMINE 3 KINASE-RELATED PROTEIN; 1.
DR   PANTHER; PTHR12149:SF9; FRUCTOSAMINE-3-KINASE; 1.
DR   Pfam; PF03881; Fructosamin_kin; 1.
DR   PIRSF; PIRSF006221; Ketosamine-3-kinase; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   neXtProt; NX_Q9H479; -.
DR   PharmGKB; PA134870460; -.
DR   TreeFam; TF313452; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Direct protein sequencing; Kinase;
KW   Nucleotide-binding; Proteomics identification; Reference proteome;
KW   Transferase.
FT   CHAIN           1..309
FT                   /note="Fructosamine-3-kinase"
FT                   /id="PRO_0000216337"
FT   ACT_SITE        217
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P9WI99"
FT   BINDING         89..91
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HA64"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:11016445"
FT   HELIX           1..9
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          14..17
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           20..23
FT                   /evidence="ECO:0007829|PDB:8UE1"
FT   TURN            25..27
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          29..33
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          38..43
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           48..65
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          66..68
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          73..78
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          84..89
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          94..97
FT                   /evidence="ECO:0007829|PDB:8UE1"
FT   HELIX           100..116
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          149..151
FT                   /evidence="ECO:0007829|PDB:9CXO"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:9CXO"
FT   STRAND          161..163
FT                   /evidence="ECO:0007829|PDB:8UE1"
FT   HELIX           164..171
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           173..184
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           187..199
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           200..203
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   TURN            204..206
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           220..222
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          223..225
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          230..232
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   STRAND          238..240
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           242..252
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           257..266
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           273..292
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           294..296
FT                   /evidence="ECO:0007829|PDB:9CX8"
FT   HELIX           297..308
FT                   /evidence="ECO:0007829|PDB:9CX8"
SQ   SEQUENCE   309 AA;  35171 MW;  BA886A86655DE28F CRC64;
     MEQLLRAELR TATLRAFGGP GAGCISEGRA YDTDAGPVFV KVNRRTQARQ MFEGEVASLE
     ALRSTGLVRV PRPMKVIDLP GGGAAFVMEH LKMKSLSSQA SKLGEQMADL HLYNQKLREK
     LKEEENTVGR RGEGAEPQYV DKFGFHTVTC CGFIPQVNEW QDDWPTFFAR HRLQAQLDLI
     EKDYADREAR ELWSRLQVKI PDLFCGLEIV PALLHGDLWS GNVAEDDVGP IIYDPASFYG
     HSEFELAIAL MFGGFPRSFF TAYHRKIPKA PGFDQRLLLY QLFNYLNHWN HFGREYRSPS
     LGTMRRLLK
//
